Doctors & patients are saying about 'A-Fib.com'...
"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."
Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN
"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."
Jill and Steve Douglas, East Troy, WI
“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP.
Faye Spencer, Boise, ID, April 2017
“I think your site has helped a lot of patients.”Dr. Hugh G. Calkins, MD Johns Hopkins,
Baltimore, MD
Empowering Patients: Review of the “Guideline for Diagnosis & Management of Atrial Fibrillation”
From time-to-time I make reference the the Management Guidelines that your cardiologist, electrophysiologist, cardiac surgeon and pharmacist follow in the treatment of your Atrial Fibrillation.
I wrote about the most recent update when it was published in January 2024 (the previous supplement was in 2019).
Know Your Rights as an Atrial Fibrillation Patient
The “2023 Guideline for the Diagnosis & Management of Atrial Fibrillation” is a 171 page document that includes several important shifts in treatment recommendations and an up-front effort to include the patient’s desires and wishes in “Shared Decision-Making”.
Example 1: A patient who doesn’t want to be on a blood thinner and would prefer a Left Atrial Appendage Occlusion device (i.e., Watchman, Amplatzer, etc.).
Example 2: A patient who doesn’t want to be on rate control medications for 3-12 months first but who wants a catheter ablation.
The Pillars of AF Management
The Guidelines are organized around the three pillars: Stroke Risk (Assess and Treat), Optimize (All Modifiable Risk Factors), and Symptoms Management (AF Burden/Rhythm control and Rate control). These are “built” on a foundation of “Shared Decision Making” between the patient and medical team.
Key Shifts in the Guidelines:
• Stages of atrial fibrillation: recognizes A-Fib as a disease continuum that requires a variety of strategies at the different stages;
• A-Fib risk factor: recognizes lifestyle and risk factor modification as a pillar of A-Fib management to prevent onset and progression;
• Catheter ablation of A-Fib: can be first-line therapy; recognizes the superiority of catheter ablation over drug therapy for rhythm control;
• Left atrial appendage occlusion devices: recognized for safety and efficacy.
What Patients Need to Know
To be an informed patient, the main points you should know are:
1. Catheter ablation is recognized as first-line therapy for most A-Fib patients.
What that means is that you no longer have to undergo months or a year on antiarrhythmic (drug) therapy before you can have a catheter ablation. Even if you’ve just been diagnosed with A-Fib, you can choose to have a catheter ablation as your first treatment option.
From the Guideline: “Catheter ablation is useful as first-line therapy to improve symptoms and reduce progression to persistent AF.”
“Early rhythm control is associated with a greater likelihood of maintaining sinus rhythm in the long term and minimizing AF burden and reducing the progression of the disease.” And it reduces the likelihood of dementia onset.
2. The Guideline emphasizes the use of catheter ablation early in the treatment of A-Fib. (Research shows patients who underwent ablation within one year of diagnosis had significantly lower recurrence rates.)
3. Direct oral anticoagulants (DOACs) are preferred over warfarin (with the exception of certain patients with, for example, a mechanical heart valve).
Aspirin is no longer recommended as an anticoagulant. “Aspirin…alone as an alternative to anticoagulation is not recommended to reduce stroke risk.”
4. Clots take time to form (e.g. “lasting ≥24 hours”). Under the new guideline, most patients whose A-Fib episodes last less than 5 minutes should not receive Oral Anticoagulant.
Before, it was thought that even a short A-Fib episode (less than 5 minutes) could cause a clot and stroke.
5. The benefits of Left Atrial Appendage Occlusion devices (i.e., Watchman, Amplatzer, etc.) may be a reasonable alternative to an Oral Anticoagulant.
6. “A-Fib burden” (how severe your A-Fib is and how it affects you) is an important factor in the your choice of treatments for your A-Fib.
What Are Your Treatment Goals?
At A-Fib.com, we always encourage patients to aim to cure their Atrial Fibrillation rather than learn to live with it. For many this is a real possibility (like me!). For some patients with other medical conditions (comorbidities), this may not be possible.
The goal should always be to aim for the best outcome for you and your type of Atrial Fibrillation.
Know that your wishes, your preferences of treatment, are front and center in the Guideline for the Diagnosis & Management of Atrial Fibrillation. Educate yourself. Make your wishes known. Be your own best patient advocate.
At A-Fib.com, we offer you the information and encouragement you need to find your A-Fib cure or best outcome for you and your treatment goals. It all starts with educating yourself!
Read it Yourself
If you want to review the Guideline yourself, it includes a Table of Contents so you can jump to and read a particular section. The entire document is on the Journal American College of Cardiology website.
You can also download a copy of the Guideline as a .PDF document and review it at your leisure.
